"Biomarkers, Tumor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS.
| Descriptor ID |
D014408
|
| MeSH Number(s) |
D23.101.140
|
| Concept/Terms |
Biomarkers, Tumor- Biomarkers, Tumor
- Tumor Biomarkers
- Markers, Biological Tumor
- Tumor Markers, Biological
- Markers, Tumor Metabolite
- Tumor Metabolite Markers
- Metabolite Markers, Tumor
- Marker, Tumor Metabolite
- Metabolite Marker, Tumor
- Tumor Metabolite Marker
- Tumor Markers, Biologic
- Biologic Tumor Markers
- Markers, Biologic Tumor
- Marker, Biologic Tumor
- Biologic Tumor Marker
- Tumor Marker, Biologic
- Biochemical Tumor Markers
- Markers, Biochemical Tumor
- Marker, Biochemical Tumor
- Biochemical Tumor Marker
- Tumor Marker, Biochemical
- Tumor Markers, Biochemical
- Carcinogen Markers
- Markers, Carcinogen
- Markers, Neoplasm Metabolite
- Neoplasm Metabolite Markers
- Marker, Neoplasm Metabolite
- Metabolite Marker, Neoplasm
- Neoplasm Metabolite Marker
- Metabolite Markers, Neoplasm
- Biological Tumor Markers
- Biological Tumor Marker
- Tumor Marker, Biological
- Marker, Biological Tumor
Markers, Tumor- Markers, Tumor
- Tumor Markers
- Biomarkers, Cancer
- Cancer Biomarkers
|
Below are MeSH descriptors whose meaning is more general than "Biomarkers, Tumor".
Below are MeSH descriptors whose meaning is more specific than "Biomarkers, Tumor".
This graph shows the total number of publications written about "Biomarkers, Tumor" by people in this website by year, and whether "Biomarkers, Tumor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 2 | 3 |
| 1997 | 3 | 7 | 10 |
| 1998 | 2 | 4 | 6 |
| 1999 | 2 | 8 | 10 |
| 2000 | 2 | 11 | 13 |
| 2001 | 3 | 11 | 14 |
| 2002 | 8 | 5 | 13 |
| 2003 | 6 | 11 | 17 |
| 2004 | 12 | 14 | 26 |
| 2005 | 13 | 10 | 23 |
| 2006 | 16 | 13 | 29 |
| 2007 | 13 | 15 | 28 |
| 2008 | 23 | 18 | 41 |
| 2009 | 21 | 25 | 46 |
| 2010 | 14 | 19 | 33 |
| 2011 | 26 | 29 | 55 |
| 2012 | 29 | 18 | 47 |
| 2013 | 29 | 30 | 59 |
| 2014 | 17 | 24 | 41 |
| 2015 | 31 | 32 | 63 |
| 2016 | 24 | 35 | 59 |
| 2017 | 31 | 29 | 60 |
| 2018 | 32 | 35 | 67 |
| 2019 | 50 | 34 | 84 |
| 2020 | 44 | 27 | 71 |
| 2021 | 28 | 36 | 64 |
| 2022 | 2 | 28 | 30 |
| 2023 | 1 | 20 | 21 |
| 2024 | 21 | 39 | 60 |
| 2025 | 22 | 14 | 36 |
To return to the timeline,
click here.
Below are the most recent publications written about "Biomarkers, Tumor" by people in Profiles.
-
Papillary renal cell carcinoma, formerly known as Type 2: a single institutional study addressing histologic and molecular features. Histopathology. 2026 Apr; 88(5):1044-1050.
-
Identifying and mitigating the biological effectors of the social determinants of health in cancer. J Natl Cancer Inst. 2025 Oct 01; 117(10):1981-1983.
-
Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology). Leukemia. 2025 Dec; 39(12):2926-2934.
-
Improving the diagnosis of leptomeningeal metastases by molecular profiling of cell-free DNA from cerebrospinal fluid. Eur J Cancer. 2025 Oct 16; 229:115783.
-
ROSIE: AI generation of multiplex immunofluorescence staining from histopathology images. Nat Commun. 2025 Aug 16; 16(1):7633.
-
HER2 and urothelial carcinoma: current understanding and future directions. Nat Rev Urol. 2026 Feb; 23(2):110-132.
-
Building digital histology models of transcriptional tumor programs with generative deep learning for pathology-based precision medicine. Genome Med. 2025 Aug 07; 17(1):87.
-
Revisionist history uncovers a simplified molecular-based classification of differentiated thyroid cancer. J Pathol. 2025 Oct; 267(2):130-141.
-
Early Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus-Associated Oropharyngeal Cancer. Clin Cancer Res. 2025 Aug 01; 31(15):3150-3159.
-
Detecting likely germline variants during tumor-based molecular profiling. J Clin Invest. 2025 Aug 01; 135(15).